- Home
- ROIV vs BURL Comparison
ROIV vs BURL Comparison
Compare ROIV & BURL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ROIV | BURL |
|---|---|---|
| Founded | 2014 | 1972 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Department/Specialty Retail Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.6B | 18.6B |
| IPO Year | N/A | 2013 |
Fundamental Metrics
Financial Performance| Metric | ROIV | BURL |
|---|---|---|
| Price | $26.32 | $302.19 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 16 |
| Target Price | $27.44 | ★ $336.57 |
| AVG Volume (30 Days) | ★ 6.9M | 797.3K |
| Earning Date | 02-06-2026 | 03-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 19.59 |
| EPS | N/A | ★ 8.72 |
| Revenue | $13,310,000.00 | ★ $11,187,977,000.00 |
| Revenue This Year | N/A | $10.29 |
| Revenue Next Year | $741.42 | $9.28 |
| P/E Ratio | ★ N/A | $34.68 |
| Revenue Growth | N/A | ★ 6.81 |
| 52 Week Low | $8.73 | $212.92 |
| 52 Week High | $27.94 | $318.49 |
Technical Indicators
Market Signals| Indicator | ROIV | BURL |
|---|---|---|
| Relative Strength Index (RSI) | 66.81 | 45.30 |
| Support Level | $26.31 | $303.58 |
| Resistance Level | $27.94 | $318.49 |
| Average True Range (ATR) | 0.97 | 9.10 |
| MACD | 0.46 | -1.30 |
| Stochastic Oscillator | 79.45 | 18.74 |
Price Performance
Historical ComparisonAbout ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
About BURL Burlington Stores Inc.
Burlington Stores Inc is off-price retailer offering an extensive selection of in-season, fashion-focused merchandise including: women's ready-to-wear apparel, menswear, youth apparel, baby, beauty, footwear, accessories, home, toys, gifts and coats. Company sell a broad selection of desirable, first-quality, current-brand, labeled merchandise acquired directly from nationally recognized manufacturers and other suppliers. Company sell product in category such as Ladies apparel, Accessories and shoes, Home, Mens apparel, Kids apparel and baby and Outerwear.